Cancer Family
Childhood Hematopoietic and Lymphoid Cell Neoplasm
CI-CAN-00000131Explore in graph →
PediatricHematologicNon-malignant103 active trials1 approved drugs14 evidence items
- NCIt
- C9431
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000131Explore in graph →
Clinical trials
567 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04325841 | Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children | completed | Phase 2 | 2 | Beijing Boren HospitalOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT05962905 | Accuracy Performance Verification of the INVOS™ System in Pediatrics(INCATH) | completed | — | 110 | Medtronic - MITGINDUSTRY | 1 | May 9, 2025 | clinicaltrials |
| NCT03898596 |
| Umbilical Vessel Catheterization Under ECG Monitoring and Guidance |
| recruiting |
| N/A |
| 150 |
| Stanford UniversityOTHER |
| 1 |
| May 1, 2025 |
| clinicaltrials |
| NCT06938009 | Dutch Registry of Pediatric Cardiac Arrest(PROGNOSE) | recruiting | — | 500 | Matthijs de HoogOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT06138145 | Inclusion Appeal Videos and Intent to Register for Pediatric Clinical Trials | completed | N/A | 125 | University of PennsylvaniaOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT03500133 | Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation.(LHGALOP2017) | recruiting | Phase 4 | 500 | Hospital JP GarrahanOTHER_GOV | 1 | Apr 16, 2025 | clinicaltrials |
| NCT06166706 | Current Practice of Ventilation Strategies in Children Undergoing General Anesthesia(BIG APPLE) | recruiting | — | 10,000 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 4 | Apr 9, 2025 | clinicaltrials |
| NCT03643276 | Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 | recruiting | Phase 3 | 5,000 | Martin SchrappeOTHER | 8 | Apr 6, 2025 | clinicaltrials |
| NCT06581081 | Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia | recruiting | N/A | 130 | Peking University People's HospitalOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT05386355 | Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool(MoVeUP) | completed | N/A | 1,934 | IDeA States Pediatric Clinical Trials NetworkNETWORK | 1 | Mar 11, 2025 | clinicaltrials |
| NCT06866873 | CD-19 CAR-T Cell for Pediatric ALL or Lymphoma | recruiting | N/A | 18 | Hong Kong Children's HospitalOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT06488456 | Psychometric Properties of the Therapy-Related Symptom Checklist-Children | completed | — | 300 | Ege UniversityOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06559345 | A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL | recruiting | Phase 2 | 276 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT06564493 | A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL | recruiting | Phase 2 | 170 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT03213691 | Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 2 | Feb 5, 2025 | clinicaltrials |
| NCT05992246 | The Ratio of Femoral Vein Diameter to Femoral Artery Diameter to Predict Fluid Responsiveness in Children | completed | — | 85 | Tanta UniversityOTHER | 1 | Feb 4, 2025 | clinicaltrials |
| NCT05215405 | Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL | no longer available | — | — | Kathleen LudwigOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT05034354 | Virtual Remote Physiological Monitoring Program of Children With Heart Disease | completed | N/A | 23 | University of AlbertaOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT06626672 | Digital Health Promotion for Children With Congenital Heart Disease and Their Guardians | recruiting | N/A | 60 | Deutsches Herzzentrum MuenchenOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT03220035 | Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) | completed | Phase 2 | 4 | National Cancer Institute (NCI)NIH | 2 | Jan 27, 2025 | clinicaltrials |
| NCT06790719 | Paediatric Breakthrough Pain Assessment(BEACON) | not yet recruiting | — | 210 | University of SouthamptonOTHER | 0 | Jan 24, 2025 | clinicaltrials |
| NCT04722848 | Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL | active not recruiting | Phase 3 | 236 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 1 | Jan 23, 2025 | clinicaltrials |
| NCT06096272 | Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy | recruiting | N/A | 30 | Children's Hospital Los AngelesOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT05528939 | Feasibility/Acceptability of Attentional-Control Training in Survivors(FAACTS) | recruiting | N/A | 50 | Children's National Research InstituteOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT05686590 | Prehospital Provider Training With Augmented Reality (AR) | completed | N/A | 22 | Thomas CarusoOTHER | 1 | Dec 16, 2024 | clinicaltrials |
| NCT03233204 | Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) | completed | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 2 | Dec 11, 2024 | clinicaltrials |
| NCT06722638 | Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia(VIRALL) | recruiting | N/A | 40 | Children's National Research InstituteOTHER | 1 | Dec 9, 2024 | clinicaltrials |
| NCT03356262 | The QUebec Adipose and Lifestyle InvesTigation in Youth (QUALITY) Cohort(QUALITY) | active not recruiting | — | 630 | St. Justine's HospitalOTHER | 0 | Dec 2, 2024 | clinicaltrials |
| NCT06711679 | Exploring the Minimum Effective Concentration and Volume of Ropivacaine for Sacral Plexus Anesthesia | enrolling by invitation | Phase 4 | 180 | Yilin ZhaoOTHER | 1 | Dec 2, 2024 | clinicaltrials |
| NCT04465370 | Pediatric Cardiac Output Monitoring Observational Study(POGO) | completed | — | 89 | Edwards LifesciencesINDUSTRY | 1 | Nov 18, 2024 | clinicaltrials |
| NCT06420076 | Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells(BAH246) | recruiting | Phase 1 / Phase 2 | 60 | Essen BiotechOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT04637113 | Singapore's Health Outcomes After Critical Illness in Kids(SHACK) | completed | — | 300 | KK Women's and Children's HospitalOTHER_GOV | 1 | Nov 7, 2024 | clinicaltrials |
| NCT04523623 | Pain Control Differences Between Oxycodone and Ibuprofen in Children With Isolated Forearm Injuries | withdrawn | N/A | 0 | Washington University School of MedicineOTHER | 0 | Oct 26, 2024 | clinicaltrials |
| NCT06654583 | Effectiveness of Developed Interactive Play Mat In Pediatric Physical Therapy | active not recruiting | N/A | 54 | Superior UniversityOTHER | 1 | Oct 23, 2024 | clinicaltrials |
| NCT04475731 | Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse | active not recruiting | Phase 2 | 67 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 1 | Oct 22, 2024 | clinicaltrials |
| NCT06410586 | Integrative Korean Medicine Treatment for Pediatrics After Traffic Accident: Retrospective Chart Review Study and Survey | completed | — | 57 | Jaseng Medical FoundationOTHER | 1 | Oct 21, 2024 | clinicaltrials |
| NCT05724030 | Use of Integrated Pulmonary Index Monitorisation in Children Undergoing Botulinum Toxin Injection | completed | N/A | 69 | Kocaeli UniversityOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06624007 | Applying Pediatric Nursing Excellence Model to Nurses in Orthopedic Surgery Care of Children | completed | N/A | 100 | Jouf UniversityOTHER | 1 | Oct 2, 2024 | clinicaltrials |
| NCT06591195 | Distraction As Multimodal Pain Management(DISTRACT) | not yet recruiting | N/A | 126 | Radboud University Medical CenterOTHER | 0 | Sep 19, 2024 | clinicaltrials |
| NCT04472286 | Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors(HBHL) | completed | — | 40 | University of NebraskaOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT06209528 | Assessing Neurophysiological and Cognitive Function in School Children(WIS) | completed | — | 17 | Life UniversityOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT04996745 | Taking POSNA's OrthoKids to the People | withdrawn | N/A | 0 | Louisiana State University Health Sciences Center in New OrleansOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT06221683 | Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML(GMCAII) | recruiting | Phase 2 | 500 | Children's Hospital of Soochow UniversityOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06316960 | Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation | recruiting | Phase 2 | 50 | Children's Hospital of Soochow UniversityOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT05452668 | Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia Patients | unknown | N/A | 51 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05622591 | ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML(Pediatric AML) | withdrawn | Phase 1 | 0 | Elucida OncologyINDUSTRY | 0 | Aug 7, 2024 | clinicaltrials |
| NCT03676504 | Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR | recruiting | Phase 1 / Phase 2 | 68 | University Hospital HeidelbergOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT04311216 | Shoulder Instability in Children: Muscle Activity and Movement | completed | — | 30 | Robert Jones and Agnes Hunt Orthopaedic and District NHS TrustOTHER_GOV | 1 | Jul 22, 2024 | clinicaltrials |
| NCT05850013 | The Measurement of Vital Signs in Children by Lifelight® Software in Comparison to the Standard of Care(VISION-Jr) | completed | — | 504 | Xim LimitedINDUSTRY | 1 | Jul 18, 2024 | clinicaltrials |
| NCT05504772 | Precision Medicine for Every Child With Cancer(ZERO2) | recruiting | — | 3,500 | Australian & New Zealand Children's Haematology/Oncology GroupOTHER | 2 | Jul 17, 2024 | clinicaltrials |
Data updated 23 days agoSource updated May 18, 2025source: clinicaltrials